AERIE PHARMACEUTICALS INC short interest in 2020
In 2020, AERIE PHARMACEUTICALS INC's disclosed short interest ran from 27.78% of shares outstanding on 15 Jan 2020 to 12.50% on 31 Dec 2020, a change of -15.28 percentage points. The year's high was 27.78% on 15 Jan 2020 and its low 12.01% on 30 Nov 2020, averaging 19.39% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.98 days on 14 Feb 2020. Full history: AERIE PHARMACEUTICALS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2020 in figures
- Start of year
- 27.78% (15 Jan 2020)
- End of year
- 12.50% (31 Dec 2020)
- Change
- -15.28 pp
- High
- 27.78% (15 Jan 2020)
- Low
- 12.01% (30 Nov 2020)
- Average
- 19.39%
- Highest days to cover
- 24.98 (14 Feb 2020)
- SEC filings marked
- 9
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 27.78% | 17.97 | |
| 31 Jan 2020 | 26.28% | 15.25 | |
| 14 Feb 2020 | 26.93% | 24.98 | |
| 28 Feb 2020 | 26.66% | 8.34 | results (8-K), 10-K filed |
| 13 Mar 2020 | 24.93% | 12.77 | |
| 31 Mar 2020 | 19.91% | 8.91 | |
| 15 Apr 2020 | 20.93% | 10.74 | results (8-K) |
| 30 Apr 2020 | 21.50% | 14.43 | |
| 15 May 2020 | 21.11% | 10.50 | results (8-K), 10-Q filed |
| 29 May 2020 | 21.23% | 10.43 | |
| 15 Jun 2020 | 19.84% | 8.94 | |
| 30 Jun 2020 | 19.36% | 14.76 | |
| 15 Jul 2020 | 17.33% | 12.03 | |
| 31 Jul 2020 | 19.78% | 17.82 | |
| 14 Aug 2020 | 17.18% | 9.53 | results (8-K), 10-Q filed |
| 31 Aug 2020 | 17.98% | 13.73 | |
| 15 Sep 2020 | 17.73% | 12.12 | |
| 30 Sep 2020 | 18.83% | 16.28 | |
| 15 Oct 2020 | 16.69% | 16.19 | |
| 30 Oct 2020 | 13.75% | 6.07 | |
| 13 Nov 2020 | 13.18% | 8.08 | results (8-K), 10-Q filed |
| 30 Nov 2020 | 12.01% | 11.78 | |
| 15 Dec 2020 | 12.05% | 13.81 | |
| 31 Dec 2020 | 12.50% | 11.80 |
See also: AERIE PHARMACEUTICALS INC's full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.